NEMO is essential for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP K13-induced gene expression and protection against death receptor-induced cell death, and its N-terminal 251 residues are sufficient for this process

Journal of Virology

Volumn 88, Issue 11, 2014, Pages 6345-6354

  Tolani, Bhairavi ^a   Matta, Hittu ^a   Gopalakrishnan, Ramakrishnan ^a   Punj, Vasu ^a   Chaudhary, Preet M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; DEATH RECEPTOR; FLICE INHIBITORY PROTEIN; HERPESVIRUS VECTOR; I KAPPA B KINASE GAMMA; TUMOR NECROSIS FACTOR ALPHA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; GENE CLUSTER; GENE EXPRESSION; GENE INTERACTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNE DEFICIENCY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DNA PRIMERS; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; JURKAT CELLS; LUCIFERASES; MICE; MICROARRAY ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, DEATH DOMAIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL PROTEINS;

EID: 84899797484     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00028-14     Document Type: Article

References (44)

1. Gupta SC, Sundaram C, Reuter S, Aggarwal BB. 2010. Inhibiting NFkappaB activation by small molecules as a therapeutic strategy. Biochim. Biophys. Acta 1799:775-787. http://dx. doi. org/10. 1016/j. bbagrm. 2010. 05. 004.
2. Aggarwal BB. 2004. Nuclear factor-kappaB: the enemy within. Cancer Cell 6:203-208. http://dx. doi. org/10. 1016/j. ccr. 2004. 09. 003.
3. Richmond A. 2002. Nf-kappa B, chemokine gene transcription and tumour growth. Nat. Rev. Immunol. 2:664-674. http://dx. doi. org/10. 1038/nri887.
4. Hayden MS, Ghosh S. 2004. Signaling to NF-kappaB. Genes Dev. 18: 2195-2224. http://dx. doi. org/10. 1101/gad. 1228704.
5. Karin M, Delhase M. 2000. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol. 12:85-98. http://dx. doi. org/10. 1006/smim. 2000. 0210.
6. Karin M. 2006. Nuclear factor-[kappa]B in cancer development and progression. Nature 441:431. http://dx. doi. org/10. 1038/nature04870.
7. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869. http://dx. doi. org/10. 1126/science. 7997879.
8. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, Knowles DM. 1996. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88:645-656.
9. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280.
10. Bertin J, Armstrong RC, Ottilie S, Martin DA, Wang Y, Banks S, Wang GH, Senkevich TG, Alnemri ES, Moss B, Lenardo MJ, Tomaselli KJ, Cohen JI. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94:1172-1176. http://dx. doi. org/10. 1073/pnas. 94. 4. 1172.
11. Hu S, Vincenz C, Buller M, Dixit VM. 1997. A novel family of viral death effector domain-containing molecules that inhibit both CD-95-and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272: 9621-9624. http://dx. doi. org/10. 1074/jbc. 272. 15. 9621.
12. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521. http://dx. doi. org/10. 1038/386517a0.
13. Chaudhary PM, Jasmin A, Eby MT, Hood L. 1999. Modulation of the NF-kappa B pathway by virally encoded death effector domainscontaining proteins. Oncogene 18:5738-5746. http://dx. doi. org/10. 1038/sj. onc. 1202976.
14. Liu L, Eby MT, Rathore N, Sinha SK, Kumar A, Chaudhary PM. 2002. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J. Biol. Chem. 277:13745-13751. http://dx. doi. org/10. 1074/jbc. M110480200.
15. Sun Q, Matta H, Chaudhary PM. 2003. The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation. Blood 101:1956-1961. http://dx. doi. org/10. 1182/blood-2002-07-2072.
16. Sun Q, Zachariah S, Chaudhary PM. 2003. The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation. J. Biol. Chem. 278:52437-52445. http://dx. doi. org/10. 1074/jbc. M304199200.
17. Matta H, Chaudhary PM. 2004. Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domainlike IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proc. Natl. Acad. Sci. USA. 101:9399-9404. http://dx. doi. org/10. 1073/pnas. 0308016101.
18. Sun Q, Matta H, Lu G, Chaudhary PM. 2006. Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation. Oncogene 25:2717-2726. http://dx. doi. org/10. 1038/sj. onc. 1209298.
19. Chugh P, Matta H, Schamus S, Zachariah S, Kumar A, Richardson JA, Smith AL, Chaudhary PM. 2005. Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. Proc. Natl. Acad. Sci. USA. 102:12885-12890. http://dx. doi. org/10. 1073/pnas. 0408577102.
20. Guasparri I, Keller SA, Cesarman E. 2004. KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199:993-1003. http://dx. doi. org/10. 1084/jem. 20031467.
21. Matta H, Surabhi RM, Zhao J, Punj V, Sun Q, Schamus S, Mazzacurati L, Chaudhary PM. 2007. Induction of spindle cell morphology in human vascular endothelial cells by human herpesvirus 8-encoded viral FLICE inhibitory protein K13. Oncogene 26:1656-1660. http://dx. doi. org/10. 1038/sj. onc. 1209931.
22. Xu Y, Ganem D. 2007. Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. J. Gen. Virol. 88:46-50. http://dx. doi. org/10. 1099/vir. 0. 82375-0.
23. Grossmann C, Podgrabinska S, Skobe M, Ganem D. 2006. Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J. Virol. 80:7179-7185. http://dx. doi. org/10. 1128/JVI. 01603-05.
24. Bagneris C, Ageichik AV, Cronin N, Wallace B, Collins M, Boshoff C, Waksman G, Barrett T. 2008. Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome. Mol. Cell 30:620-631. http://dx. doi. org/10. 1016/j. molcel. 2008. 04. 029.
25. Harhaj EW, Good L, Xiao G, Uhlik M, Cvijic ME, Rivera-Walsh I, Sun SC. 2000. Somatic mutagenesis studies of NF-kappa B signaling in human T cells: evidence for an essential role of IKK gamma in NF-kappa B activation by T-cell costimulatory signals and HTLV-I Tax protein. Oncogene 19:1448-1456. http://dx. doi. org/10. 1038/sj. onc. 1203445.
26. Matta H, Gopalakrishnan R, Graham C, Tolani B, Khanna A, Yi H, Suo Y, Chaudhary PM. 2012. Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-kappaB pathway independent of TRAF6, TAK1 and LUBAC. PLoS One 7:e36601. http://dx. doi. org/10. 1371/journal. pone. 0036601.
27. Remy I, Michnick SW. 2006. A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat. Methods 3:977-979. http://dx. doi. org/10. 1038/nmeth979.
28. Remy I, Michnick SW. 2004. Mapping biochemical networks with protein-fragment complementation assays. Methods Mol. Biol. 261:411-426. http://dx. doi. org/10. 1385/1-59259-762-9:411.
29. Matta H, Sun Q, Moses G, Chaudhary PM. 2003. Molecular genetic analysis of human herpes virus 8-encoded viral FLICE inhibitory proteininduced NF-kappaB activation. J. Biol. Chem. 278:52406-52411. http://dx. doi. org/10. 1074/jbc. M307308200.
30. Zhao J, Punj V, Matta H, Mazzacurati L, Schamus S, Yang Y, Yang T, Hong Y, Chaudhary PM. 2007. K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis. PLoS One 2:e1067. http://dx. doi. org/10. 1371/journal. pone. 0001067.
31. Alkharsah KR, Singh VV, Bosco R, Santag S, Grundhoff A, Konrad A, Sturzl M, Wirth D, Dittrich-Breiholz O, Kracht M, Schulz TF. 2011. Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells. J. Virol. 85:10375-10388. http://dx. doi. org/10. 1128/JVI. 00226-11.
32. Rudolph D, Yeh WC, Wakeham A, Rudolph B, Nallainathan D, Potter J, Elia AJ, Mak TW. 2000. Severe liver degeneration and lack of NFkappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14: 854-862. http://dx. doi. org/10. 1101/gad. 14. 7. 854.
33. Punj V, Matta H, Schamus S, Chaudhary PM. 2009. Integrated microarray and multiplex cytokine analyses of Kaposi's sarcoma associated herpesvirus viral FLICE inhibitory protein K13 affected genes and cytokines in human blood vascular endothelial cells. BMC Med. Genomics 2:50. http://dx. doi. org/10. 1186/1755-8794-2-50.
34. Punj V, Matta H, Chaudhary PM. 2012. A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma. PLoS One 7:e37498. http://dx. doi. org/10. 1371/journal. pone. 0037498.
35. Keller SA, Hernandez-Hopkins D, Vider J, Ponomarev V, Hyjek E, Schattner EJ, Cesarman E. 2006. NF-{kappa}B is essential for progression of KSHV-and EBV-infected lymphomas in vivo. Blood 107:3295-3302. http://dx. doi. org/10. 1182/blood-2005-07-2730.
36. Morris K. 2003. Cancer? In Africa? Lancet Oncol. 4:5. http://dx. doi. org/10. 1016/S1470-2045(03)00969-0.
37. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW. 1993. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int. J. Cancer 54:26-36. http://dx. doi. org/10. 1002/ijc. 2910540106.
38. Sturzl M, Hohenadl C, Zietz C, Castanos-Velez E, Wunderlich A, Ascherl G, Biberfeld P, Monini P, Browning PJ, Ensoli B. 1999. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J. Natl. Cancer Inst. 91:1725-1733. http://dx. doi. org/10. 1093/jnci/91. 20. 1725.
39. Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS. 1998. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J. Virol. 72:1005-1012.
40. Zhao T, Yang L, Sun Q, Arguello M, Ballard DW, Hiscott J, Lin R. 2007. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat. Immunol. 8:592-600. http://dx. doi. org/10. 1038/ni1465.
41. Israel A. 2010. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb. Perspect. Biol. 2:a000158. http://dx. doi. org/10. 1101/cshperspect. a000158.
42. Courtois G, Smahi A. 2006. NF-kappaB-related genetic diseases. Cell Death Differ. 13:843-851. http://dx. doi. org/10. 1038/sj. cdd. 4401841.
43. Belanger C, Gravel A, Tomoiu A, Janelle ME, Gosselin J, Tremblay MJ, Flamand L. 2001. Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation. J. Hum. Virol. 4:62-73.
44. Aggarwal BB. 2000. Apoptosis and nuclear factor-kappa B: a tale of association and dissociation. Biochem. Pharmacol. 60:1033-1039. http://dx. doi. org/10. 1016/S0006-2952(00)00393-2.